Workshop Overview
This course investigates the how, what, and why of the USA Regulatory Framework. It is an advanced course that will help you understand the key role of the FDA and its division as well as help you identify the different types of applications for registration of product in USA. In addition, you will get an overview of pharmacovigilance, labelling and advertising requirements and become aware of process of communicating with FDA.
After attending this course, participants should be able to:
Nisha has extensive experience of 20 years and has demonstrated considerable expertise in the field of Regulatory Affairs, handled various market applications in US, EU, ASEAN nations and India. In India, Nisha was heading Corporate Regulatory Affairs Department for Pharma Solutions business group at Piramal Enterprises limited headquartered in Mumbai, India. She was in-charge of Formulations, API, Local FDA and artworks groups and her key role was devising regulatory strategy for all submissions, devising regulatory policy for the organisation and ensuring regulatory compliance during audits by Health Authorities. Under her leadership, the team achieved approvals for various submissions to US and EU of different dosage forms. She has successful track record of handling inspections by US and EU authorities. In Australia, she had briefly worked as Project Manager for Neo health OTC and in her current role at ARCS, is responsible for growing the educational offering for regulatory medicines and pharmacovigilance professionals. Nisha is a registered pharmacist (BPharm) from India and has an Executive MBA from IIM, Calcutta, one of the most reputed and globally recognised management institutions.
Who should attend
Regulatory affairs professionals involved in preparing global submissions and those interacting with USA colleagues.
Upon completion of this workshop, attendees will receive 7 CPD points
This is an advanced course for those with 3 years’ experience in Regulatory Affairs or with a particular need to understand the USA regulatory framework. Understanding of CTD, drug development and clinical development is assumed. If you have any questions on your suitability for this course, do not hesitate to call the ARCS office on (02) 8905 0829.
Workshop fees (incl. GST):
Early bird - until 29 March 2023
ARCS Member - $540
Retired/Student Member - $405
Non Member - $885
Standard – from 30 March 2023
ARCS Member - $710
Retired/Student Member - $540
Non Member - $1140
Registration terms and conditions
Please note that virtual workshops at ARCS cover the same content as the physical (face-to-face) workshop. The training material, exercises and student workbook have been redesigned to ensure that the same learning outcomes are achieved as traditional workshops.
The registration fees for virtual workshops have been reduced by $150 per person, per workshop day to reflect the reduction in venue and catering costs associated with a face-to-face workshop.
This workshop runs for one full day from 09:00-17:00
Attendee requirements:
If you're interested in taking this course, please provide your information below, and we'll inform you about the upcoming session's schedule.